Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
time decrease » time increased (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
Showing 3,301 - 3,320 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((time decrease) OR (greatest decrease)) ))', query time: 0.69s Refine Results
  1. 3301
    Metformin rescues PGC-1α expression in presence of inhibitor.

    Metformin rescues PGC-1α expression in presence of inhibitor. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 3302
    Metformin increases PGC-1α and TFAM expression.

    Metformin increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3303
    Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α.

    Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 3304
    Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage.

    Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 3305
    Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB.

    Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 3306
    NTM infection induces mitochondrial damage and reduces mitochondria number.

    NTM infection induces mitochondrial damage and reduces mitochondria number. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 3307
    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics

    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 3308
    Age-specific incidence trends of HFMD in Guangzhou from 2013 to 2023.

    Age-specific incidence trends of HFMD in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 3309
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 3310
    Average proportion of first choice female applicants stratified by specialty category.

    Average proportion of first choice female applicants stratified by specialty category. by Lucy Hui (17538542)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 3311
    Temporal Trends and Forecasting of Hand, Foot, and Mouth Disease.

    Temporal Trends and Forecasting of Hand, Foot, and Mouth Disease. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 3312
    Gender-specific incidence trends of HFMD in Guangzhou from 2013 to 2023.

    Gender-specific incidence trends of HFMD in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 3313
    Temporal distribution of HFMD incidence in Guangzhou from 2013 to 2023.

    Temporal distribution of HFMD incidence in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 3314
    Flowchart of patient selection in this study.

    Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 3315
    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment.

    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 3316
    Age-specific and gender-specific incidence trends of HFMD in Guangzhou, 2013–2023.

    Age-specific and gender-specific incidence trends of HFMD in Guangzhou, 2013–2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 3317
    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics

    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 3318
    Gender differences in first choice match outcomes.

    Gender differences in first choice match outcomes. by Lucy Hui (17538542)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 3319
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 3320
    Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole.

    Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: